Measurement and quality control issues in multiplex protein assays: a case study.
about
Antibody-based protein multiplex platforms: technical and operational challenges.Quality control, analysis and secure sharing of Luminex® immunoassay data using the open source LabKey Server platform.Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis studyAqueous two-phase system patterning of detection antibody solutions for cross-reaction-free multiplex ELISAExploring the use of internal and externalcontrols for assessing microarray technical performanceValidation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples.Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use.Early identification of cardiovascular risk using genomics and proteomics.Multiplexed method to calibrate and quantitate fluorescence signal for allergen-specific IgE.Performance of multiplex cytokine assays in serum and saliva among community-dwelling postmenopausal women.Associations between inflammation and cognitive function in African Americans and European AmericansAntibody colocalization microarray: a scalable technology for multiplex protein analysis in complex samples.A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal FluidSequential multiplexed analyte quantification using peptide immunoaffinity enrichment coupled to mass spectrometrySimple Plex(™) : A Novel Multi-Analyte, Automated Microfluidic Immunoassay Platform for the Detection of Human and Mouse Cytokines and Chemokines.Microfluidic strategies applied to biomarker discovery and validation for multivariate diagnostics.Interferometric silicon biochips for label and label-free DNA and protein microarrays.Protein microarray technology: how far off is routine diagnostics?Cytokine Concentrations Measured by Multiplex Assays in Canine Peripheral Blood Samples.The effects of tether placement on antibody stability on surfaces.The Utility of Multiplex Assays for Identification of Proteomic Signatures in Psychiatry.Translating pharmacodynamic biomarkers from bench to bedside: analytical validation and fit-for-purpose studies to qualify multiplex immunofluorescent assays for use on clinical core biopsy specimens.Development and validation of protein microarray technology for simultaneous inflammatory mediator detection in human sera.Opportunities and Challenges of Multiplex Assays: A Machine Learning Perspective.Associations Between Serum Inflammatory Markers and Hippocampal Volume in a Community Sample.Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX™: planar microarray diagnosis.The association between cigarette smoking and inflammation: The Genetic Epidemiology Network of Arteriopathy (GENOA) studyPre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis.Accuracy and reproducibility of a multiplex immunoassay platform: a validation study.Measurement error correction in the least absolute shrinkage and selection operator model when validation data are available.
P2860
Q28396909-CC13F41F-54D2-49A6-B3E2-56D8411BC5BAQ30620607-1A56F8B1-338F-4F37-ABB2-07CEA6EE12DEQ33530066-38C766C1-DE15-4F1B-93CB-59D4FD13DF3CQ33554539-2056458E-67D5-43D4-A24F-BD78E64FEA8EQ33781434-5D9806B4-C580-48D2-9D06-CC1EB4834004Q33997620-EF419C80-86E6-4A25-8810-16342207E2DBQ34071983-BAAAB0E8-363E-4952-B5B8-47B5373DA531Q34129889-FD9A2450-E6F8-4BB1-9088-B4E118F40759Q34230534-8D128D71-188B-4D2C-8559-313BFA806739Q34663573-1156D572-7D06-48FC-8153-A028068B53DEQ34729552-8396D960-B120-4659-BC03-8402C04EC5A9Q35878752-2DD9BB99-2453-4EAD-B604-95C3AC91BE42Q35999591-11D0ACD7-A6EE-44B1-A3B0-0866DB737C1AQ36208981-A92A12C9-8225-4AFA-B4F6-8BE08B9112AFQ37375502-839BEA4E-C1F7-4922-9142-E3B1577F2FACQ37943855-4F34B826-4A88-4519-8078-03E4039AF0ECQ38038828-08483EAC-C2AB-4184-849B-A7536A648A61Q38170231-78D2E2C3-D054-44E4-BEDE-6511EC2BA1ADQ38622504-93638258-AC4B-4600-B55E-1B980076FC1AQ38747988-2B94240D-09D6-45F5-BFED-371D69D9CF67Q38869523-4550B493-50C3-4820-B338-3AF2BC252CD3Q38963126-E73C75B7-97CD-45E1-A680-3D6AE4E5133BQ39100710-466F38F8-8C2F-4AC0-B8CA-64A0CE788290Q39146393-C301A193-13E1-47F8-A33E-A4E828015654Q39466046-BDBC4672-6F47-4BFF-A2F5-C393DCA01284Q39920872-999F81AA-2D88-42C4-BD75-F39FBC65A36BQ41702511-A4A6E2D4-240B-4CAA-B2D3-A5AA41567205Q41773090-F591C57A-18C7-4FB8-B206-AA11CCC23987Q41971260-1BA608BB-17DD-4410-82B5-1633AED19F72Q47427341-3CB18858-B0F5-41C3-989F-9B6BE075716E
P2860
Measurement and quality control issues in multiplex protein assays: a case study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Measurement and quality control issues in multiplex protein assays: a case study.
@ast
Measurement and quality control issues in multiplex protein assays: a case study.
@en
Measurement and quality control issues in multiplex protein assays: a case study.
@nl
type
label
Measurement and quality control issues in multiplex protein assays: a case study.
@ast
Measurement and quality control issues in multiplex protein assays: a case study.
@en
Measurement and quality control issues in multiplex protein assays: a case study.
@nl
prefLabel
Measurement and quality control issues in multiplex protein assays: a case study.
@ast
Measurement and quality control issues in multiplex protein assays: a case study.
@en
Measurement and quality control issues in multiplex protein assays: a case study.
@nl
P2093
P2860
P1433
P1476
Measurement and quality control issues in multiplex protein assays: a case study.
@en
P2093
Allison A Ellington
George G Klee
Iftikhar J Kullo
Kent R Bailey
P2860
P304
P356
10.1373/CLINCHEM.2008.120717
P407
P577
2009-04-16T00:00:00Z